Meta-Analysis of the Placebo Rates of Clinical Relapse and Severe Endoscopic Recurrence in Postoperative Crohn's Disease
Authors:
- Calogero CammàCCCalogero Cammà
- Irene ModestoIMIrene Modesto
- Giuseppe CabibboGCGiuseppe Cabibbo
- Daniela ScimecaDSDaniela Scimeca
- Giuseppe CivitavecchiaGCGiuseppe Civitavecchia
- Filippo MocciaroFMFilippo Mocciaro
- Ambrogio OrlandoAOAmbrogio Orlando
- Marco EneaMEMarco Enea
- Mario CottoneMCMario Cottone
- 1 November 2008
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 135 (5) , 1500-1509
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- The Placebo Effect for Gastroenterology: Tool or TormentClinical Gastroenterology and Hepatology, 2006
- Outcomes of placebo therapy in inflammatory bowel diseaseInflammatory Bowel Diseases, 2006
- Ornidazole for prophylaxis of postoperative Crohn’s disease recurrence: A randomized, double-blind, placebo-controlled trialGastroenterology, 2005
- Postoperative maintenance of Crohn’s disease remission with 6-mercaptopurine, mesalamine, or placebo: A 2-year trialGastroenterology, 2004
- Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GGGut, 2002
- Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's diseaseGut, 2001
- Medical Therapy To Reduce Postoperative Crohn's Disease RecurrenceAmerican Journal of Gastroenterology, 2000
- Controlled trial of metronidazole treatment for prevention of crohn's recurrence after ileal resectionGastroenterology, 1995
- Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's diseaseGastroenterology, 1995
- Predictability of the postoperative course of Crohn's diseaseGastroenterology, 1990